InvestorsHub Logo
Followers 116
Posts 1877
Boards Moderated 0
Alias Born 11/22/2017

Re: None

Wednesday, 06/03/2020 6:51:31 PM

Wednesday, June 03, 2020 6:51:31 PM

Post# of 701759
For those who follow Autolomous:

remember this:
4 months ago:

Happy and Excited to announce that we have been working with Advent Bioservices on developing & deploying our AutoloMATE eBMR solution. We look forward to continuing our partnership with Mike Scott and the Advent Team. (https://www.autolomous.com/linkedin)



Autolomous
14 hours ago:

We are proud to announce Autolomous has been chosen by Glycostem Therapeutics, for the digitisation of the manufacturing and release of Glycostem's hashtag#NK-cell therapies for clinical trials and beyond.



Comment Kwok Pang (Chief Operating Officer at Autolomous )
11 hours ago:

Our deployment to Glycostem Therapeutics represent a significant milestone for , it is our first deployment to a hashtag#Allogeneic hashtag#ATMP manufacturer and our first deployment in Europe, showcasing the flexibility of the hashtag#AutoloMATE platform and the value-add it brings. We are excited to be working with Troels Jordansen, Volker Huppert and the Glycostem Therapeutics team.


I'm proud of the progress the Autolomous team have made, a US deployment is not far behind.


https://www.linkedin.com/in/kwokpang/detail/recent-activity/

hmmm….."a US deployment is not far behind."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News